PFE Earnings Pfizer
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q3 2026 | 2026-09-27 | 0.56 | 2026-11-03 | 10-Q |
| Q2 2026 | 2026-06-28 | -0.04 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-29 | 0.47 | 2026-05-05 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.29 | 2026-02-26 | 10-K |
| FY 2025 | 2025-12-31 | 1.36 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-28 | 0.62 | 2025-11-04 | 10-Q |
| Q2 2025 | 2025-06-29 | 0.51 | 2025-08-05 | 10-Q |
| Q1 2025 | 2025-03-30 | 0.52 | 2025-05-05 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 0.07 | 2025-02-27 | 10-K |
| FY 2024 | 2024-12-31 | 1.41 | 2025-02-27 | 10-K |
| Q3 2024 | 2024-09-29 | 0.78 | 2024-11-04 | 10-Q |
| Q2 2024 | 2024-06-30 | 0.01 | 2024-08-05 | 10-Q |
| Q1 2024 | 2024-03-31 | 0.55 | 2024-05-08 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -0.59 | 2024-02-22 | 10-K |
| FY 2023 | 2023-12-31 | 0.37 | 2024-02-22 | 10-K |
| Q3 2023 | 2023-10-01 | -0.42 | 2023-11-08 | 10-Q |
| Q2 2023 | 2023-07-02 | 0.41 | 2023-08-09 | 10-Q |
| Q1 2023 | 2023-04-02 | 0.97 | 2023-05-10 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 0.86 | 2023-02-23 | 10-K |
| FY 2022 | 2022-12-31 | 5.47 | 2023-02-23 | 10-K |
| Q3 2022 | 2022-10-02 | 1.51 | 2022-11-09 | 10-Q |
| Q2 2022 | 2022-07-03 | 1.73 | 2022-08-10 | 10-Q |
| Q1 2022 | 2022-04-03 | 1.37 | 2022-05-11 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 0.59 | 2022-02-24 | 10-K |
| FY 2021 | 2021-12-31 | 3.85 | 2022-02-24 | 10-K |
| Q3 2021 | 2021-10-03 | 1.42 | 2021-11-12 | 10-Q |
| Q2 2021 | 2021-07-04 | 0.98 | 2021-08-12 | 10-Q |
| Q1 2021 | 2021-04-04 | 0.86 | 2021-05-13 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | 0.15 | 2021-02-25 | 10-K |
| FY 2020 | 2020-12-31 | 1.63 | 2021-02-25 | 10-K |
| Q3 2020 | 2020-09-27 | 0.26 | 2020-11-05 | 10-Q |
| Q2 2020 | 2020-06-28 | 0.62 | 2020-08-06 | 10-Q |
| Q1 2020 | 2020-03-29 | 0.60 | 2020-05-07 | 10-Q |
| Q4 2019 (derived) | 2019-12-31 | -0.11 | 2020-02-27 | 10-K |
| FY 2019 | 2019-12-31 | 2.82 | 2020-02-27 | 10-K |
| Q3 2019 | 2019-09-29 | 1.36 | 2019-11-07 | 10-Q |
| Q2 2019 | 2019-06-30 | 0.89 | 2019-08-08 | 10-Q |
| Q1 2019 | 2019-03-31 | 0.68 | 2019-05-09 | 10-Q |
| Q4 2018 (derived) | 2018-12-31 | -0.06 | 2019-02-28 | 10-K |
| FY 2018 | 2018-12-31 | 1.87 | 2019-02-28 | 10-K |
| Q3 2018 | 2018-09-30 | 0.69 | 2018-11-08 | 10-Q |
| Q2 2018 | 2018-07-01 | 0.65 | 2018-08-09 | 10-Q |
| Q1 2018 | 2018-04-01 | 0.59 | 2018-05-10 | 10-Q |
| Q4 2017 (derived) | 2017-12-31 | 2.03 | 2018-02-22 | 10-K |
| FY 2017 | 2017-12-31 | 3.52 | 2018-02-22 | 10-K |
| Q3 2017 | 2017-10-01 | 0.47 | 2017-11-09 | 10-Q |
| Q2 2017 | 2017-07-02 | 0.51 | 2017-08-10 | 10-Q |
| Q1 2017 | 2017-04-02 | 0.51 | 2017-05-11 | 10-Q |
| Q4 2016 (derived) | 2016-12-31 | 0.13 | 2017-02-23 | 10-K |
| FY 2016 | 2016-12-31 | 1.17 | 2017-02-23 | 10-K |
| Q3 2016 | 2016-10-02 | 0.22 | 2016-11-10 | 10-Q |
| Q2 2016 | 2016-07-03 | 0.33 | 2016-08-11 | 10-Q |
| Q1 2016 | 2016-04-03 | 0.49 | 2016-05-12 | 10-Q |
| Q4 2015 (derived) | 2015-12-31 | -0.03 | 2016-02-29 | 10-K |
| FY 2015 | 2015-12-31 | 1.11 | 2016-02-29 | 10-K |
| Q3 2015 | 2015-09-27 | 0.34 | 2015-11-05 | 10-Q |
| Q2 2015 | 2015-06-28 | 0.42 | 2015-08-06 | 10-Q |
| Q1 2015 | 2015-03-29 | 0.38 | 2015-05-07 | 10-Q |
| Q4 2014 (derived) | 2014-12-31 | 0.19 | 2015-02-27 | 10-K |
| FY 2014 | 2014-12-31 | 1.42 | 2015-02-27 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.